Fig. 11

A Cytotoxic activity of the AgNPs, S18, and Nanocomposite (AgNPs\S18) against hepatic cellular carcinoma cells (HepG-2). B Cytotoxic activity of the AgNPs, S18, and Nanocomposite (AgNPs\S18) against a regular human liver epithelial cell line (THLE-2). C (IC50) of the green synthesized AgNPs, S18, and Nanocomposite (AgNPs\S18) against (HepG-2) and (THLE-2)